Stent News and Research

RSS

A stent is a small mesh tube that’s used to treat narrowed or weakened arteries in the body.

You may have a stent placed in an artery as part of a procedure called angioplasty (AN-jee-oh-plas-tee). Angioplasty can restore blood flow through narrowed or blocked arteries. Stents help prevent arteries from becoming narrowed or blocked again in the months or years after treatment with angioplasty. You may also have a stent placed in a weakened artery to improve blood flow and to help prevent the artery from bursting.

Stents are usually made of metal mesh, but sometimes they’re made of fabric. Fabric stents, also called stent grafts, are used in larger arteries. Some stents are coated with medicines that are slowly and continuously released into the artery. These medicines help prevent the artery from becoming blocked again.

Invatec launches Maris Plus self-expanding peripheral stent system

Invatec, a comprehensive innovator of interventional products, today launched its latest self-expanding peripheral stent system, Maris Plus in new 6, 7 and 8mm diameters, ideal for interventions involving the superficial femoral arteries (SFA). The 9, 10 and 12mm diameters of the stent are already marketed for the iliac artery.

27 Jan 2010

FDA approves first heart valve conduit that can delay need for open-heart surgery

The U.S. Food and Drug Administration today approved the Medtronic Melody Transcatheter Pulmonary Valve and Ensemble Delivery System, the first heart valve to be implanted through a catheter, or tube, in a leg vein and guided up to the heart. This new approach to the treatment of adults and children with previously implanted, poorly functioning pulmonary valve conduits can delay the need for open-heart surgery.

27 Jan 2010

Acacia Research subsidiary acquires rights to intraluminal device technology patent

Acacia Research Corporation announced today that a subsidiary has acquired the rights to a patent for intraluminal device technology.

25 Jan 2010

OrbusNeich's clinical data demonstrates the benefits of Genous Bio-engineered R stent

OrbusNeich announced that clinical data presented today at Asia PCR/Singapore LIVE 2010 demonstrated the benefits of the Genous Bio-engineered R stent in the treatment of two challenging patient subsets.

24 Jan 2010

Researchers set on grand challenge to accomplish targeted drug delivery for heart disease

Virginia Tech researcher Pavlos Vlachos and his students in the College of Engineering have a tall order to tackle: Stem the grim progression of heart disease, which kills hundreds of thousands of people each year in the United States alone.

23 Jan 2010

UK Gill Heart Institute offers individualized fitness program for heart patients

How do you change health habits among a population with some of the highest heart disease rates in the world? Tackling heart disease in Kentucky - an epicenter of heart health problems - the University of Kentucky Gill Heart Institute Cardiac Rehabilitation Program is helping high-risk patients make radical, lasting changes to improve their heart health.

23 Jan 2010

Emerging Healthcare Solutions and ThromboVision complete due diligence process under new option agreement

Emerging Healthcare Solutions, Inc. and ThromboVision have completed phase one of their due diligence process under their new option agreement.

21 Jan 2010

U.S. District Court finds Johnson & Johnson patents as invalid

Boston Scientific Corporation (NYSE: BSX) announced today that the U.S. District Court for the District of Delaware has found all four patents in a suit involving Johnson & Johnson to be invalid.

21 Jan 2010

$SIR supports use of vertebral augmentation for patients with spine fractures$

SIR supports use of vertebral augmentation for patients with spine fractures

Given the current controversy over vertebroplasty-a minimally invasive treatment performed by interventional radiologists in individuals with painful osteoporotic vertebral compression fractures that fail to respond to conventional medical therapy-what's a patient to do?

20 Jan 2010

Cook Medical presents latest advancements at ISET 2010 International Symposium on Endovascular Therapy

Signaling its continued commitment to addressing the anatomy of the entire peripheral vasculature and combating disease with targeted diagnostic and interventional devices, Cook Medical is presenting its latest advancements at the ISET 2010 International Symposium on Endovascular Therapy.

20 Jan 2010

Invatec's REEF HP PTA Balloon Catheter receives FDA marketing clearance

Invatec, a comprehensive innovator of cardiovascular products, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its REEF HP™, a PTA Balloon Catheter, for use in peripheral high pressure dilatation procedures. The “lesion-specific” design of the balloon material is particularly useful in hard-to-dilate situations.

19 Jan 2010

USPTO grants Endologix's requests to reexamine Cook’s patent claims

Endologix, Inc., developer of minimally invasive treatments for aortic disorders, announced today that the United States Patent and Trademark Office (USPTO) has granted both of Endologix's requests for reexamination of the two patents asserted by Cook, Inc. in the lawsuit filed in October 2009 against Endologix.

18 Jan 2010

Boston Scientific commences patient enrollment in its WallFlex Biliary RX Fully Covered Stent trial

Boston Scientific Corporation today announced that the first patient has been enrolled in a clinical trial to evaluate its WallFlex® Biliary RX Fully Covered Stent for the treatment of benign bile duct strictures. This multi-center, prospective study plans to enroll 187 patients at 11 centers worldwide over the next 18 months.

17 Jan 2010

Svelte Medical Systems initiates European clinical trial for SOAW delivery system

Svelte Medical Systems, Inc. is pleased to announce that it has initiated its European clinical trial at the Thoraxcenter Research Center in Rotterdam, the Netherlands for its “Stent-on-a-Wire” (SOAW) cobalt–chromium Bare Metal Stent.

9 Jan 2010

Boston Scientific's PROMUS Everolimus-Eluting Coronary Stent System receives Japanese marketing approval

Boston Scientific Corporation announced today that it has received approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) to market its PROMUS® Everolimus-Eluting Coronary Stent System for the treatment of coronary artery disease. The Company plans to launch the product as soon as reimbursement approval is granted, which is expected in the coming weeks.

9 Jan 2010

Japanese MHLW approves Abbott's XIENCE V Everolimus Eluting Coronary Stent System

Abbott announced today that the Japanese Ministry of Health, Labor and Welfare (MHLW) has approved its XIENCE V® Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease.

8 Jan 2010

Sinexus renamed as Intersect ENT; begins clinical study on new bioabsorbable stent

Sinexus has changed its name to Intersect ENT. Intersect's initial focus is a bioabsorbable drug eluting stent to treat patients with chronic sinusitis, a debilitating condition that affects 37 million people each year and is more prevalent than heart disease or asthma.

8 Jan 2010

Emerging Healthcare Solutions seeks business opportunities with new, patented T-Guide Platelet Function Analyzer

Emerging Healthcare Solutions, Inc. under their exclusive option agreement with Thrombovision, has begun due diligence to aggressively seek the establishment of business opportunities with the new patented T-Guide Platelet Function Analyzer.

8 Jan 2010

Treatment with Effient more cost effective, show TRITON-TIMI 38 clinical trial results

Results from a health economic substudy of the TRITON-TIMI 38 clinical trial showed that among patients with acute coronary syndromes (ACS) managed with percutaneous coronary intervention (PCI), including stenting, treatment with Effient(®) (prasugrel) compared with branded clopidogrel (Plavix(®)) was more cost effective, and in most cases cost saving.

6 Jan 2010

ART publishes impressive data on its bioresorbable stent

Arterial Remodeling Technologies (“ART”) announced today that it has disclosed impressive in vivo and in vitro data related to its bioresorbable stent platform—data that validates the Company’s approach to simultaneously balance biocompatibility, biomechanics and bioresorption in a bioresorbable PLA (polylactic acid) stent without altering healing by drug elution from the stent platform.

5 Jan 2010

Stent News and Research

Further Reading

Invatec launches Maris Plus self-expanding peripheral stent system

FDA approves first heart valve conduit that can delay need for open-heart surgery

Acacia Research subsidiary acquires rights to intraluminal device technology patent

OrbusNeich's clinical data demonstrates the benefits of Genous Bio-engineered R stent

Researchers set on grand challenge to accomplish targeted drug delivery for heart disease

UK Gill Heart Institute offers individualized fitness program for heart patients

Emerging Healthcare Solutions and ThromboVision complete due diligence process under new option agreement

U.S. District Court finds Johnson & Johnson patents as invalid

SIR supports use of vertebral augmentation for patients with spine fractures

Cook Medical presents latest advancements at ISET 2010 International Symposium on Endovascular Therapy

Invatec's REEF HP PTA Balloon Catheter receives FDA marketing clearance

USPTO grants Endologix's requests to reexamine Cook’s patent claims

Boston Scientific commences patient enrollment in its WallFlex Biliary RX Fully Covered Stent trial

Svelte Medical Systems initiates European clinical trial for SOAW delivery system

Boston Scientific's PROMUS Everolimus-Eluting Coronary Stent System receives Japanese marketing approval

Japanese MHLW approves Abbott's XIENCE V Everolimus Eluting Coronary Stent System

Sinexus renamed as Intersect ENT; begins clinical study on new bioabsorbable stent

Emerging Healthcare Solutions seeks business opportunities with new, patented T-Guide Platelet Function Analyzer

Treatment with Effient more cost effective, show TRITON-TIMI 38 clinical trial results

ART publishes impressive data on its bioresorbable stent

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News